<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7297311</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0234723</article-id><article-id pub-id-type="publisher-id">PONE-D-19-29114</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Epidemiology</subject><subj-group><subject>HIV epidemiology</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Infectious diseases</subject><subj-group><subject>Viral diseases</subject><subj-group><subject>HIV infections</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>HIV clinical manifestations</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Epidemiology</subject><subj-group><subject>Medical Risk Factors</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Sexually Transmitted Diseases</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Surgical and Invasive Medical Procedures</subject><subj-group><subject>Reproductive System Procedures</subject><subj-group><subject>Circumcision</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and Places</subject><subj-group><subject>Geographical Locations</subject><subj-group><subject>Africa</subject><subj-group><subject>Mozambique</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Factors associated with HIV serodiscordance among couples in Mozambique: Comparison of the 2009 INSIDA and 2015 IMASIDA surveys</article-title><alt-title alt-title-type="running-head">Comparison of the 2009 INSIDA and 2015 IMASIDA surveys - Mozambique</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6966-1825</contrib-id><name><surname>Juga</surname><given-names>Adelino J. C.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Software</role><role content-type="http://credit.casrai.org/">Visualization</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1881-0637</contrib-id><name><surname>Hens</surname><given-names>Niel</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Visualization</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Osman</surname><given-names>Nafissa</given-names></name><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Supervision</role><xref ref-type="aff" rid="aff005"><sup>5</sup></xref><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Aerts</surname><given-names>Marc</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Visualization</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Department of Mathematics and Informatics, Faculty of Sciences, Eduardo Mondlane University, Maputo, Mozambique</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>I-BioStat, Data Science Institute, Hasselt University, Diepenbeek, Belgium</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Epidemiology and Social Medicine (ESOC), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Department of Obstetrics and Gynecology, Maputo Central Hospital, Maputo, Mozambique</addr-line></aff><aff id="aff006"><label>6</label>
<addr-line>Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Wang</surname><given-names>Zixin</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>The Chinese University of Hong Kong, HONG KONG</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>adelino.juga@gmail.com</email></corresp></author-notes><pub-date pub-type="epub"><day>16</day><month>6</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>15</volume><issue>6</issue><elocation-id>e0234723</elocation-id><history><date date-type="received"><day>18</day><month>10</month><year>2019</year></date><date date-type="accepted"><day>2</day><month>6</month><year>2020</year></date></history><permissions><license xlink:href="https://creativecommons.org/publicdomain/zero/1.0/"><license-p>This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0234723.pdf"/><abstract><p>Recent studies suggest that a large proportion of new HIV-1 infections in mature epidemics occurs within discordant couples, making discordancy a major contributor to the spread of HIV/AIDS in Africa. This paper aims at assessing changes over a five-year period (2009&#x02013;2015) on the (risk) factors associated with HIV serodiscordance among couples in Mozambique, using cross-sectional data from the INSIDA and IMASIDA surveys. The pooled data of both surveys were analyzed using a joint model for three parameters characterizing in a particular way disagreement and sero(con/dis)corance between the HIV statuses of couples, as introduced by Aerts et al.: the probability that the female partner is HIV positive, given that both partners differ in their HIV status, the probability that only one partner is HIV positive, given that at least one of the two partners is positive (&#x0201c;positive&#x0201d; serodiscordance), and the probability that both partners are negative given that at most one of the two partners is positive (&#x0201c;negative&#x0201d; seroconcordance). The results reveal similar significant factors and estimates as in Aerts et al. (HIV prevalence, union number for woman, STI for man, condom use by woman and wealth index), but the additional significant factors &#x0201c;condom use by man&#x0201d; (no use had a negative effect on the positive serodiscordance) and &#x0201c;union number for man&#x0201d; (for couples where the man has been married or co-habiting with a woman before had a decreased negative seroconcordance) were identified. The only factor that had a different effect over time (IMASIDA as compared to INSIDA) was the effect of &#x0201c;HIV prevalence of province&#x0201d; on the negative seroconcordance. The negative effect of a higher HIV prevalence was less pronounced in 2015 for negative seroconcordance.</p></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100009550</institution-id><institution>Universiteit Hasselt</institution></institution-wrap></funding-source><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6966-1825</contrib-id><name><surname>Juga</surname><given-names>Adelino J. C.</given-names></name></principal-award-recipient></award-group><funding-statement>This study was financially supported by the Flemish Interuniversity Council (VLIR-UOS) in collaboration with Eduardo Mondlane University (UEM) through the DESAFIO Program, in Mozambique to AJCJ.</funding-statement></funding-group><counts><fig-count count="0"/><table-count count="3"/><page-count count="11"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the manuscript and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the manuscript and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>HIV continues to be a major global public health issue, having claimed more than 35 million lives so far. In 2017, 940 000 people died from HIV-related causes globally. There were approximately 36.9 million people living with HIV at the end of 2017 with 1.8 million people in 2017 globally. According to the World Health Organization (WHO), the African region is the most affected region, with 25.7 million people living with HIV in 2017. The African region also accounts for almost two-thirds of the global total of new HIV infections [<xref rid="pone.0234723.ref001" ref-type="bibr">1</xref>].</p><p>A large proportion of new HIV infections in mature epidemics occur within discordant couples, making discordancy a major contributor to the spread of HIV/AIDS in Africa [<xref rid="pone.0234723.ref002" ref-type="bibr">2</xref>,<xref rid="pone.0234723.ref003" ref-type="bibr">3</xref>]. Most of these new infections occurred within heterosexual and serodiscordant stable couple relationships [<xref rid="pone.0234723.ref004" ref-type="bibr">4</xref>]. In East Africa, 40% to 50% of the married or cohabitating HIV infected persons are in an HIV-discordant partnership [<xref rid="pone.0234723.ref005" ref-type="bibr">5</xref>]. Around 15% of Mozambican cohabiting couples were infected by HIV in 2009; that is, either one or both members are HIV-positive [<xref rid="pone.0234723.ref003" ref-type="bibr">3</xref>]. This rate increased to 16,7% in 2015 [<xref rid="pone.0234723.ref006" ref-type="bibr">6</xref>], suggesting that HIV discordance (when one member of a couple is HIV-positive and the other is HIV negative) may be responsible for a substantial percentage of all new HIV infections [<xref rid="pone.0234723.ref007" ref-type="bibr">7</xref>]. Global estimates of HIV serodiscordance vary from country to country (e.g. in Vietnam it was 58% in 2016 [<xref rid="pone.0234723.ref008" ref-type="bibr">8</xref>]). In Mozambique, the global estimate of HIV serodiscordance was 0.68 (95%CI [0.63, 0.72]) in 2009 [<xref rid="pone.0234723.ref009" ref-type="bibr">9</xref>], which decreased to 0.57(95%CI [0.52, 0.62]) in 2015.</p><p>Risk factors associated with HIV serodiscordance among couples have been widely investigated [<xref rid="pone.0234723.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0234723.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0234723.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0234723.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0234723.ref012" ref-type="bibr">12</xref>]. Eyawo et al. [<xref rid="pone.0234723.ref004" ref-type="bibr">4</xref>] reviewed several published as well as unpublished articles and found that women were as likely as men to be the index partner in discordant couple. A case-control study conducted by Habte et al. [<xref rid="pone.0234723.ref011" ref-type="bibr">11</xref>] in Ethiopia found that 5.8% and 2.6% of all couples were either male and female discordant, respectively. This study reveals that rare use of condom and active tuberculosis at enrolment were predictors associated with serodiscordance. On the other hand, Uah et al. [<xref rid="pone.0234723.ref010" ref-type="bibr">10</xref>] found that the probability of a couple being female discordant was associated with a history of at least two terminations of pregnancy and five or more total lifetime sexual partnerships. The HIV status disclosure rate in this study was 83.7%; with significantly higher disclosure rate in concordant couples (83.3%) compared to 76.8% among women in serodiscordant relationships.</p><p>Using the second Mozambican demographic health survey (DHS) data conducted in 2009, designated as INSIDA, Fishel et al. [<xref rid="pone.0234723.ref003" ref-type="bibr">3</xref>] conducted the first serodiscordance analysis. Their research used two separate logistic regression models. One model compared concordant positive couples with all discordant couples while the second model compared concordant positive couples with male discordant as well as with female discordant couples [<xref rid="pone.0234723.ref003" ref-type="bibr">3</xref>]. Their study did find only a weak association between HIV serodiscordance and polygamy status (yes/no) as well as between HIV serodiscordance and the amount of time passed since the couple last had sexual intercourse [<xref rid="pone.0234723.ref003" ref-type="bibr">3</xref>]. Juga et al. [<xref rid="pone.0234723.ref009" ref-type="bibr">9</xref>] and Aerts et al. [<xref rid="pone.0234723.ref013" ref-type="bibr">13</xref>] re-analyzed the INSIDA data by fitting flexible marginal and random effects models to adequately and directly describe the conditional &#x0201c;positive&#x0201d; serodiscordance measure (CDM, defined as the probability that only one partner is HIV positive, given that at least one of the two partners is positive), as a new alternative discordance measure of the HIV status for woman and man within a couple. Aerts et al. [<xref rid="pone.0234723.ref013" ref-type="bibr">13</xref>] found that the HIV prevalence for the province where a couple was located (varying from 3,7% in Niassa to 25.1% in Gaza [<xref rid="pone.0234723.ref006" ref-type="bibr">6</xref>]), the &#x0201c;union number for woman&#x0201d;, the &#x0201c;STI of man&#x0201d; (presence of symptoms of sexually transmitted infections), and the &#x0201c;wealth index&#x0201d; were associated with the serodiscordance measure CDM. In addition, the probability to be serodiscordant did vary across enumeration areas (EAs).</p><p>Mozambique conducted the third DHS survey in 2015, designated as the IMASIDA survey. In this paper, we use the model of Aerts et al. [<xref rid="pone.0234723.ref013" ref-type="bibr">13</xref>] on the pooled dataset of the INSIDA and IMASIDA surveys. while accounting for the study designs of both surveys. Main objective is to investigate the hypothesis that there are no changes over the five-year period (2009&#x02013;2015), based on both surveys; and more specifically the hypothesis that the same risk factors have the same effect on the CDM. Additionally, it is of interest whether this hypothesis of no changes also holds for the other two parameters in the model: the probability that the female partner is HIV positive, given that both partners differ in their HIV status, and the probability that both partners are negative given that at most one of the two partners is positive.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and methods</title><sec id="sec003"><title>INSIDA and IMASIDA study design</title><p>The first Mozambican national and demographic health survey of prevalence, risk behavioural and information about HIV and AIDS (INSIDA) was conducted in 2009 [<xref rid="pone.0234723.ref003" ref-type="bibr">3</xref>] while the second, designated as the IMASIDA survey [<xref rid="pone.0234723.ref006" ref-type="bibr">6</xref>], took place in 2015. These two surveys were designed to collect comprehensive data on the prevalence of HIV infection, knowledge, attitude, behaviour risk factors and access to information on HIV and AIDS in the Mozambican population. Both surveys were cross-sectional two-stage surveys. Moreover, stratification and cluster sampling methods were applied to ensure that for each province inference was possible with nearly the same precision. EAs, households and individuals were Primary Sampling Units (PSU), Secondary Sampling Units (SSU) and Tertiary Sampling Units (TSU) respectively [<xref rid="pone.0234723.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0234723.ref006" ref-type="bibr">6</xref>].</p><p>The INSIDA survey selected randomly 270 EAs from 45000 EAs defined according to the 2007 general population and housing census. A total of 122 EAs were sampled from urban areas and 148 EAs from rural areas. In the IMASIDA survey, 307 EAs were also randomly sampled from 45000 EAs (from 2007 general population and housing census), 134 EAs from in urban areas and 173 EAs from rural areas. A fixed number of households were systematically selected within each EA in both surveys [<xref rid="pone.0234723.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0234723.ref006" ref-type="bibr">6</xref>]. Men and women aged between 15&#x02013;59 years were eligible to participate in an individual interview and to provide a blood sample for HIV testing. During the individual interviews, respondents were asked if they were married, and if so, who their spouse/wife was. If the spouse/wife was named in the household questionnaire, the interviewer recorded the household line number of the spouse/wife in the individual&#x02019;s questionnaire. Through a methodology standardized by the DHS project, cohabiting couples are matched together, allowing for an analysis of their HIV status and other characteristics. The datasets of both surveys are accessible at <ext-link ext-link-type="uri" xlink:href="https://dhsprogram.com/data/available-datasets.cfm">https://dhsprogram.com/data/available-datasets.cfm</ext-link> by selecting Mozambique, the year of the survey, and submitting a research project proposal.</p></sec><sec id="sec004"><title>Description of variables</title><p>Variables used in the analysis are briefly described in <xref rid="pone.0234723.t001" ref-type="table">Table 1</xref>. The HIV status (infected yes/no) for both members within a couple are the (binary) response variables of interest. The following covariates were used in the model building process. The variable wealth index refers to the economic status of the couple and condom use by man and woman refers to whether the male, respectively female partner used a male, respectively female condom the last time the man, respectively woman had sexual intercourse with the other partner. Union number for woman/man refers to whether the individual has been married or cohabiting with a man/woman once or more than once. Genital discharge refers to whether a woman had genital discharge while genital sore/ulcer refers to whether a woman had a genital sore/ulcer in the last 12 months. The number of partners for woman and man refers to the total number of sexual partners including the current partner in the last 12 months.</p><table-wrap id="pone.0234723.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0234723.t001</object-id><label>Table 1</label><caption><title>INSIDA and IMASIDA variables: Basic description of variables.</title></caption><alternatives><graphic id="pone.0234723.t001g" xlink:href="pone.0234723.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" style="border-top:thick;border-bottom:thick" rowspan="1" colspan="1">Variables name</th><th align="left" style="border-top:thick;border-bottom:thick" rowspan="1" colspan="1">Type</th><th align="left" style="border-top:thick;border-bottom:thick" rowspan="1" colspan="1">Categories</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">HIV status for woman</td><td align="left" rowspan="1" colspan="1">Binary</td><td align="left" rowspan="1" colspan="1">0: HIV Negative (ref. category)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1: HIV Positive</td></tr><tr><td align="left" rowspan="2" colspan="1">HIV status for man</td><td align="left" rowspan="1" colspan="1">Binary</td><td align="left" rowspan="1" colspan="1">0: HIV Negative (ref. category)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1: HIV Positive</td></tr><tr><td align="left" rowspan="2" colspan="1">Union number for woman</td><td align="left" rowspan="1" colspan="1">Binary</td><td align="left" rowspan="1" colspan="1">0: once (ref. category)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1: more than once</td></tr><tr><td align="left" rowspan="2" colspan="1">Union number for man</td><td align="left" rowspan="1" colspan="1">Binary</td><td align="left" rowspan="1" colspan="1">0: once (ref. category)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1: more than once</td></tr><tr><td align="left" rowspan="2" colspan="1">Genital discharge for woman</td><td align="left" rowspan="1" colspan="1">Binary</td><td align="left" rowspan="1" colspan="1">0: no (ref. category)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1: yes</td></tr><tr><td align="left" rowspan="2" colspan="1">Genital sore/ulcer for woman</td><td align="left" rowspan="1" colspan="1">Binary</td><td align="left" rowspan="1" colspan="1">0: no (ref. category)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1: yes</td></tr><tr><td align="left" rowspan="2" colspan="1">Condom use by man (male condom)</td><td align="left" rowspan="1" colspan="1">Binary</td><td align="left" rowspan="1" colspan="1">0: no (ref. category)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1: yes</td></tr><tr><td align="left" rowspan="2" colspan="1">Condom use by woman (female condom)</td><td align="left" rowspan="1" colspan="1">Binary</td><td align="left" rowspan="1" colspan="1">0: no (ref. category)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1: yes</td></tr><tr><td align="left" rowspan="2" colspan="1">Survey indicator</td><td align="left" rowspan="1" colspan="1">Binary</td><td align="left" rowspan="1" colspan="1">0: INSIDA (ref. survey)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1: IMASIDA</td></tr><tr><td align="left" rowspan="2" colspan="1">Male circumcision</td><td align="left" rowspan="1" colspan="1">Binary</td><td align="left" rowspan="1" colspan="1">0: no (ref. category)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1: yes</td></tr><tr><td align="left" rowspan="2" colspan="1">STID for man</td><td align="left" rowspan="1" colspan="1">Binary</td><td align="left" rowspan="1" colspan="1">0: no (ref. category)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1: yes</td></tr><tr><td align="left" rowspan="3" colspan="1">Couple&#x02019;s wealth index</td><td align="left" rowspan="1" colspan="1">Multicategory</td><td align="left" rowspan="1" colspan="1">0: poor</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1: middle</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2: rich (ref. category)</td></tr><tr><td align="left" rowspan="3" colspan="1">HIV Prevalence of province</td><td align="left" rowspan="1" colspan="1">Multicategory</td><td align="left" rowspan="1" colspan="1">0: [&#x0003c; 5%] (ref. category)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1: [5%&#x02013;15%]</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2: [&#x0003e; 15%]</td></tr><tr><td align="left" rowspan="1" colspan="1">Number of partners for woman</td><td align="left" rowspan="1" colspan="1">Discrete</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" style="border-bottom:thick" rowspan="1" colspan="1">Number of partners for man</td><td align="left" style="border-bottom:thick" rowspan="1" colspan="1">Discrete</td><td align="left" style="border-bottom:thick" rowspan="1" colspan="1">-</td></tr></tbody></table></alternatives></table-wrap><p>The survey indicator is a binary variable indicating whether it concerns an observation of the INSIDA or the IMASIDA survey. The HIV prevalence for province was categorized into three categories using cut points of 5% and 15%. Male circumcision shows whether the male partner was circumcised or not. STID refers to whether the man had sexually transmitted infectious disease (STID) or symptoms of STID in the past 12 months. The variable Condom use by man had 1.24% of missingness, followed by Genital discharge and Genital sore/ulcer with 0.74% and Union number for man with 0.49% of missing values. However, analyses of this paper were performed using complete cases only.</p></sec><sec id="sec005"><title>Measuring con(dis)cordance</title><p>Suppose that <italic>y</italic><sub><italic>ij</italic></sub> = (<italic>y</italic><sub><italic>ij</italic>1</sub>, <italic>y</italic><sub><italic>ij</italic>2</sub>) denotes the HIV status (1 if positive, 0 if negative) of a (female, male)-couple <italic>j</italic> = 1, &#x02026;, <italic>n</italic><sub><italic>i</italic></sub> in EA <italic>i</italic> with <italic>n</italic><sub><italic>i</italic></sub> sampled couples, <italic>i</italic> = 1, &#x02026;, <italic>N</italic> and <italic>x</italic><sub><italic>ij</italic></sub> vectors of covariates or risk factors. For the INSIDA data, a total of <inline-formula id="pone.0234723.e001"><alternatives><graphic xlink:href="pone.0234723.e001.jpg" id="pone.0234723.e001g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M1"><mml:mrow><mml:munderover><mml:mo stretchy="false">&#x02211;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>2159</mml:mn></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula> couples were sampled while a total of <inline-formula id="pone.0234723.e002"><alternatives><graphic xlink:href="pone.0234723.e002.jpg" id="pone.0234723.e002g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M2"><mml:mrow><mml:munderover><mml:mo stretchy="false">&#x02211;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>2021</mml:mn></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula> couples were sampled in the IMASIDA survey. A relationship between the outcome vectors <italic>y</italic><sub><italic>ij</italic></sub> and the covariates vectors <italic>x</italic><sub><italic>ij</italic></sub> can be established. In the sequel, the dependency of <italic>x</italic><sub><italic>ij</italic></sub> on the indices <italic>i</italic> and <italic>j</italic> as well as the dependency of parameters on <italic>x</italic><sub><italic>ij</italic></sub> is sometimes suppressed to simplify notation.</p><p>The model arises from the decomposition of the joint probabilities (given covariate variables <italic>x</italic><sub><italic>ij</italic></sub>)
<disp-formula id="pone.0234723.e003"><alternatives><graphic xlink:href="pone.0234723.e003.jpg" id="pone.0234723.e003g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M3"><mml:msub><mml:mrow><mml:mo>&#x003c0;</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mtext>j</mml:mtext></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mspace width="2pt"/><mml:msub><mml:mrow><mml:mtext>j</mml:mtext></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mtext>P</mml:mtext><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mtext>y</mml:mtext></mml:mrow><mml:mrow><mml:mtext>ij</mml:mtext><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mtext>j</mml:mtext></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mtext>y</mml:mtext></mml:mrow><mml:mrow><mml:mtext>ij</mml:mtext><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mtext>j</mml:mtext></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mspace width="2pt"/><mml:mo>|</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mspace width="2pt"/></mml:mrow><mml:mo>)</mml:mo><mml:mo>,</mml:mo><mml:mspace width="1em"/><mml:msub><mml:mrow><mml:mtext>j</mml:mtext></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mspace width="2pt"/><mml:msub><mml:mrow><mml:mtext>j</mml:mtext></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mspace width="2pt"/><mml:mn>1</mml:mn></mml:math></alternatives><label>(1)</label></disp-formula>
with <inline-formula id="pone.0234723.e004"><alternatives><graphic xlink:href="pone.0234723.e004.jpg" id="pone.0234723.e004g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M4"><mml:msub><mml:mrow><mml:mn>0</mml:mn><mml:mo>&#x0003c;</mml:mo><mml:mo>&#x003c0;</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mtext>j</mml:mtext></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mspace width="2pt"/><mml:msub><mml:mrow><mml:mtext>j</mml:mtext></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo><mml:mo>&#x0003c;</mml:mo><mml:mn>1</mml:mn></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0234723.e005"><alternatives><graphic xlink:href="pone.0234723.e005.jpg" id="pone.0234723.e005g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M5"><mml:mrow><mml:msubsup><mml:mo stretchy="false">&#x02211;</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mrow><mml:msub><mml:mrow><mml:mo>&#x003c0;</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mtext>j</mml:mtext></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mspace width="2pt"/><mml:msub><mml:mrow><mml:mtext>j</mml:mtext></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mspace width="2pt"/></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>. Typically these joint probabilities are reparametrized in terms of <italic>&#x003c0;</italic><sub>1</sub>+(<italic>x</italic><sub><italic>ij</italic></sub>) = <italic>&#x003c0;</italic><sub>10</sub>(<italic>x</italic><sub><italic>ij</italic></sub>) + <italic>&#x003c0;</italic><sub>11</sub>(<italic>x</italic><sub><italic>ij</italic></sub>), and <italic>&#x003c0;</italic><sub>+1</sub>+(<italic>x</italic><sub><italic>ij</italic></sub>) = <italic>&#x003c0;</italic><sub>01</sub>(<italic>x</italic><sub><italic>ij</italic></sub>) + <italic>&#x003c0;</italic><sub>11</sub>(<italic>x</italic><sub><italic>ij</italic></sub>), the &#x0201c;marginal&#x0201d; probability of a positive HIV test for the female and male partner respectively, together with an &#x0201c;association&#x0201d; parameter <italic>&#x003b8;</italic>(<italic>x</italic><sub><italic>ij</italic></sub>), relating the HIV status of both partners. Statistical models then specify the functional dependency of the parameters <italic>&#x003c0;</italic><sub>1+</sub>(<italic>x</italic><sub><italic>ij</italic></sub>), <italic>&#x003c0;</italic><sub>+1</sub>(<italic>x</italic><sub><italic>ij</italic></sub>) and <italic>&#x003b8;</italic>(<italic>x</italic><sub><italic>ij</italic></sub>) on the covariates and risk factors <italic>x</italic><sub><italic>ij</italic></sub>. In literature, there are many dependency parameters such as the correlation, <inline-formula id="pone.0234723.e006"><alternatives><graphic xlink:href="pone.0234723.e006.jpg" id="pone.0234723.e006g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M6"><mml:mi>&#x003c1;</mml:mi><mml:mo>=</mml:mo><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mn>11</mml:mn></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>/</mml:mo><mml:msqrt><mml:msub><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:msqrt></mml:math></alternatives></inline-formula>, the odds ratio (OR), <italic>&#x003d5;</italic> = (<italic>&#x003c0;</italic><sub>00</sub><italic>&#x003c0;</italic><sub>11</sub>)/(<italic>&#x003c0;</italic><sub>01</sub><italic>&#x003c0;</italic><sub>10</sub>), and the dependence ratio (DR), <italic>&#x003c4;</italic> = <italic>&#x003c0;</italic><sub>11</sub>/(<italic>&#x003c0;</italic><sub>01</sub><italic>&#x003c0;</italic><sub>10</sub>). Faes et al. [<xref rid="pone.0234723.ref014" ref-type="bibr">14</xref>] stated that although the OR is an attractive association measure with nice mathematical properties, it is less suitable to quantify concordance due to its symmetry, treating 0&#x000b1;0 matches of equal importance as 1&#x000b1;1 matches. Following the same ideas as Faes et al. [<xref rid="pone.0234723.ref014" ref-type="bibr">14</xref>], Juga et al. [<xref rid="pone.0234723.ref009" ref-type="bibr">9</xref>] defined the HIV conditional &#x0201c;positive&#x0201d; (sero)discordance measure (CDM) as
<disp-formula id="pone.0234723.e007"><alternatives><graphic xlink:href="pone.0234723.e007.jpg" id="pone.0234723.e007g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M7"><mml:mtext>CDM</mml:mtext><mml:mo>=</mml:mo><mml:mi>P</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mtext>y</mml:mtext></mml:mrow><mml:mrow><mml:mtext>ij</mml:mtext><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>&#x02260;</mml:mo><mml:msub><mml:mrow><mml:mtext>y</mml:mtext></mml:mrow><mml:mrow><mml:mtext>ij</mml:mtext><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mrow><mml:mtext>y</mml:mtext></mml:mrow><mml:mrow><mml:mtext>ij</mml:mtext><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mtext>y</mml:mtext></mml:mrow><mml:mrow><mml:mtext>ij</mml:mtext><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>&#x02265;</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mn>10</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mn>01</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mn>10</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mn>01</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mn>11</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:math></alternatives></disp-formula>
the conditional probability that the couple is HIV discordant, given that at least one of them, man or woman, is HIV positive, They showed that the CDM measure is a more direct and relevant measure to study the effects of risk factors associated with HIV serodiscordance.</p><p>Aerts et al. [<xref rid="pone.0234723.ref013" ref-type="bibr">13</xref>] proposed a new improved parameterization based on three parammeters: the CDM as defined above, the conditional &#x0201c;negative&#x0201d; (sero)concordance measure (CSM) being the probability that both are agreeing (both negative), given that at most one is positive:
<disp-formula id="pone.0234723.e008"><alternatives><graphic xlink:href="pone.0234723.e008.jpg" id="pone.0234723.e008g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M8"><mml:mtext>CSM</mml:mtext><mml:mo>=</mml:mo><mml:mi>P</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mtext>y</mml:mtext></mml:mrow><mml:mrow><mml:mtext>ij</mml:mtext><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mtext>y</mml:mtext></mml:mrow><mml:mrow><mml:mtext>ij</mml:mtext><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mrow><mml:mtext>y</mml:mtext></mml:mrow><mml:mrow><mml:mtext>ij</mml:mtext><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mtext>y</mml:mtext></mml:mrow><mml:mrow><mml:mtext>ij</mml:mtext><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>&#x02264;</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mn>00</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mn>00</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mn>10</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mn>01</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:math></alternatives></disp-formula>
and the conditional probability that the female partner is positive, given that both disagree:
<disp-formula id="pone.0234723.e009"><alternatives><graphic xlink:href="pone.0234723.e009.jpg" id="pone.0234723.e009g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M9"><mml:mtext>CFP</mml:mtext><mml:mo>=</mml:mo><mml:mi>P</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mtext>y</mml:mtext></mml:mrow><mml:mrow><mml:mtext>ij</mml:mtext><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>|</mml:mo><mml:msub><mml:mrow><mml:mtext>y</mml:mtext></mml:mrow><mml:mrow><mml:mtext>ij</mml:mtext><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>&#x02260;</mml:mo><mml:msub><mml:mrow><mml:mtext>y</mml:mtext></mml:mrow><mml:mrow><mml:mtext>ij</mml:mtext><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mn>10</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mn>10</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mn>01</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:math></alternatives></disp-formula></p><p>For more details on these parameters, their properties and their joint estimation, see Aerts et al. [<xref rid="pone.0234723.ref013" ref-type="bibr">13</xref>].</p></sec><sec id="sec006"><title>Joint marginal and random effect model specification</title><p>The dependency of the three conditional probabilities CDM, CSM and CFP on covariates can be modeled with three components:
<disp-formula id="pone.0234723.e010"><alternatives><graphic xlink:href="pone.0234723.e010.jpg" id="pone.0234723.e010g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M10"><mml:msub><mml:mrow><mml:mtext>h</mml:mtext></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:mtext>CFP</mml:mtext><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:msubsup><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msubsup><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mspace width="1em"/><mml:msub><mml:mrow><mml:mtext>h</mml:mtext></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:mtext>CDM</mml:mtext><mml:mspace width="2pt"/><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:msubsup><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msubsup><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mspace width="1em"/><mml:msub><mml:mrow><mml:mtext>h</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:mtext>CSM</mml:mtext><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:msubsup><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msubsup><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:math></alternatives></disp-formula>
where h<sub>1</sub>, h<sub>2</sub>, and h<sub>3</sub> are appropriate link functions. We prefer the logit function as in classical logistic regression model, since all parameters are probabilities, and the logit link allows the interpretation of covariate effects in terms of odds ratios. The parameters <inline-formula id="pone.0234723.e011"><alternatives><graphic xlink:href="pone.0234723.e011.jpg" id="pone.0234723.e011g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M11"><mml:msubsup><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mspace width="2pt"/><mml:msubsup><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> are unknown regression coefficients (intercept and slopes) for each the set of covariates <italic>x</italic><sub><italic>ij</italic></sub> and can be different or (partly) in common.</p><p>As CDM, CSM and CFP are expected to be heterogeneous across EAs and should reflect the design of the surveys, the logit models have to be extended with an EA random effect as follows, expressing that the covariates x<sub>1,ij</sub>, x<sub>2,ij</sub> and x<sub>3,ij</sub> can be possibly different subvectors of the full covariate/factor x<sub>ij</sub>:
<disp-formula id="pone.0234723.e012"><alternatives><graphic xlink:href="pone.0234723.e012.jpg" id="pone.0234723.e012g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M12"><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mtext>logit</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mtext>CFP</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msubsup><mml:mi>&#x003b2;</mml:mi><mml:mn>1</mml:mn><mml:mi>T</mml:mi></mml:msubsup><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mrow><mml:mtext>CFP</mml:mtext><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mspace width="2pt"/></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mtext>logit</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mtext>CDM</mml:mtext><mml:mspace width="2pt"/><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msubsup><mml:mo>&#x003b2;</mml:mo><mml:mn>2</mml:mn><mml:mtext>T</mml:mtext></mml:msubsup><mml:msub><mml:mtext>x</mml:mtext><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mtext>ij</mml:mtext></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>b</mml:mtext><mml:mrow><mml:mtext>CDM</mml:mtext><mml:mo>,</mml:mo><mml:mtext>i</mml:mtext></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mtext>logit</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mtext>CSM</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msubsup><mml:mi>&#x003b2;</mml:mi><mml:mn>3</mml:mn><mml:mi>T</mml:mi></mml:msubsup><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mrow><mml:mtext>CSM</mml:mtext><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives><label>(2)</label></disp-formula>
where
<disp-formula id="pone.0234723.e013"><alternatives><graphic xlink:href="pone.0234723.e013.jpg" id="pone.0234723.e013g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M13"><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mtext>b</mml:mtext></mml:mrow><mml:mrow><mml:mtext>CFP</mml:mtext><mml:mo>,</mml:mo><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo></mml:mrow></mml:msub><mml:mspace width="2pt"/><mml:msub><mml:mrow><mml:mtext>b</mml:mtext></mml:mrow><mml:mrow><mml:mtext>CDM</mml:mtext><mml:mo>,</mml:mo><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo></mml:mrow></mml:msub><mml:mspace width="2pt"/><mml:msub><mml:mrow><mml:mtext>b</mml:mtext></mml:mrow><mml:mrow><mml:mtext>CSM</mml:mtext><mml:mo>,</mml:mo><mml:mtext>i</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo><mml:mo>~</mml:mo><mml:msub><mml:mrow><mml:mtext>N</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mo>&#x02211;</mml:mo></mml:mrow><mml:mo>)</mml:mo><mml:mo>,</mml:mo></mml:math></alternatives></disp-formula>
are trivariate normally distributed random EA-effects, with mean zero-vector and covariance matrix &#x02211;. The variance components <inline-formula id="pone.0234723.e014"><alternatives><graphic xlink:href="pone.0234723.e014.jpg" id="pone.0234723.e014g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M14"><mml:msubsup><mml:mrow><mml:mi>&#x003c3;</mml:mi></mml:mrow><mml:mrow><mml:mtext>CFP</mml:mtext></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mspace width="2pt"/><mml:msubsup><mml:mrow><mml:mi>&#x003c3;</mml:mi></mml:mrow><mml:mrow><mml:mtext>CDM</mml:mtext></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0234723.e015"><alternatives><graphic xlink:href="pone.0234723.e015.jpg" id="pone.0234723.e015g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M15"><mml:msubsup><mml:mrow><mml:mi>&#x003c3;</mml:mi></mml:mrow><mml:mrow><mml:mtext>CSM</mml:mtext></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> (diagonal elements of the &#x02211;-matrix) quantify the degree of heterogeneity across the AEs for each of the three parameters. Different choices for the covariance matrix were considered (partial and full-correlated random effects; partial and full shared random effects; partial and full equal random effects and lastly independent random effects). For more details on the different models and covariance matrix &#x02211; specifications and the estimation of all parameters with maximum likelihood, we refer to Aerts et al. [<xref rid="pone.0234723.ref013" ref-type="bibr">13</xref>].</p><sec id="sec007"><title>Accounting for survey design</title><p>Both INSIDA and IMASIDA surveys used stratification and clustering sampling methods, with a two-stage sampling procedure to access individuals within a household. This type of survey may sample certain groups or strata at higher rates than others, in order to ensure sufficient precision for group-specific estimates and for bias reduction. We assigned weights to observations to account for this over-sampling. For more details on the INSIDA and IMASIDA weights calculation, we refer to Juga et al. [<xref rid="pone.0234723.ref009" ref-type="bibr">9</xref>] and Reed [<xref rid="pone.0234723.ref006" ref-type="bibr">6</xref>], respectively.</p></sec></sec></sec><sec sec-type="results" id="sec008"><title>Results</title><p><xref rid="pone.0234723.t002" ref-type="table">Table 2</xref> shows the number of parameters, the Akaike information criterion (AIC, smaller values indicate a better fit [<xref rid="pone.0234723.ref015" ref-type="bibr">15</xref>]) and Bayesian information criterion (BIC, smaller values indicate a better fit, BIC tends to select simpler models than AIC [<xref rid="pone.0234723.ref016" ref-type="bibr">16</xref>]) goodness of fit measures of all fitted models. The last two columns show the models' ranks according to their AIC and BIC values.</p><table-wrap id="pone.0234723.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0234723.t002</object-id><label>Table 2</label><caption><title>Comparison of marginal model, and full-shared, partial-shared, full-equal partial-equal, full-independent, partial-correlated and full-correlated random-effects models.</title></caption><alternatives><graphic id="pone.0234723.t002g" xlink:href="pone.0234723.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Model</th><th align="center" rowspan="1" colspan="1">Number of parameters</th><th align="center" rowspan="1" colspan="1">AIC</th><th align="center" rowspan="1" colspan="1">BIC</th><th align="center" rowspan="1" colspan="1">Rank according to AIC</th><th align="center" rowspan="1" colspan="1">Rank According to BIC</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">MM (marginal model)</td><td align="center" rowspan="1" colspan="1">22</td><td align="char" char="." rowspan="1" colspan="1">4893.0</td><td align="char" char="." rowspan="1" colspan="1">5030.9</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">8</td></tr><tr><td align="left" rowspan="1" colspan="1">PS (partial-shared RE model)</td><td align="center" rowspan="1" colspan="1">24</td><td align="char" char="." rowspan="1" colspan="1">4838.2</td><td align="char" char="." rowspan="1" colspan="1">4927.6</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">FS (full-shared RE model)</td><td align="center" rowspan="1" colspan="1">25</td><td align="char" char="." rowspan="1" colspan="1">4840.2</td><td align="char" char="." rowspan="1" colspan="1">4933.3</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">PE (partial-equal RE model)</td><td align="center" rowspan="1" colspan="1">23</td><td align="char" char="." rowspan="1" colspan="1">4841.2</td><td align="char" char="." rowspan="1" colspan="1">4926.9</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">FS (full-equal RE model)</td><td align="center" rowspan="1" colspan="1">23</td><td align="char" char="." rowspan="1" colspan="1">4852.5</td><td align="char" char="." rowspan="1" colspan="1">4938.2</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">FS (full-independent RE model)</td><td align="center" rowspan="1" colspan="1">24</td><td align="char" char="." rowspan="1" colspan="1">4846.1</td><td align="char" char="." rowspan="1" colspan="1">4935.5</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">5</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>PC (partial-correlated RE model)</bold></td><td align="center" rowspan="1" colspan="1"><bold>25</bold></td><td align="char" char="." rowspan="1" colspan="1"><bold>4836.4</bold></td><td align="char" char="." rowspan="1" colspan="1"><bold>4929.4</bold></td><td align="center" rowspan="1" colspan="1"><bold>1</bold></td><td align="center" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">FC (full-correlated RE model)</td><td align="center" rowspan="1" colspan="1">28</td><td align="char" char="." rowspan="1" colspan="1">4838.3</td><td align="char" char="." rowspan="1" colspan="1">4942.6</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">7</td></tr></tbody></table></alternatives></table-wrap><p>According to AIC, the model with partial-correlated random effects (<italic>b</italic><sub>CDM,<italic>i</italic></sub>, <italic>b</italic><sub>CSM,<italic>i</italic></sub>) and no random effect (<italic>b</italic><sub>CFP,<italic>i</italic></sub>) is the best fitting model, closely followed by a partial-shared random-effects model (AIC values of 4836.4 and 4838.2 respectively). The best model according to BIC is the partial-equal random-effects model, closely followed by the partial-shared random-effects model and the partial-correlated random effects model. We opted for the partial-correlated random effects as our final model, as the same model was selected by Aerts et al. [<xref rid="pone.0234723.ref013" ref-type="bibr">13</xref>], facilitating the comparison of the new analysis on the pooled data with the analysis on the INSIDA survey only. At first glance, the new extended analysis is very much in line with that of Aerts et al. [<xref rid="pone.0234723.ref013" ref-type="bibr">13</xref>]. The factors &#x0201c;HIV prevalence of province&#x0201d;, &#x0201c;union number for woman&#x0201d;, &#x0201c;STID for man&#x0201d; and &#x0201c;wealth index&#x0201d; are significant for one or more parameters CFP, CDM and CSM and the estimates are quite similar. On the other hand, &#x0201c;condom use by woman&#x0201d; which was having a significant effect on the CFP, is no longer significant for any of the parameters. Some other additional significant factors showed up: &#x0201c;condom use by man&#x0201d; (for CDM) and &#x0201c;number of partners of man&#x0201d; (for CFP). The random effect of enumeration was significant for both parameters CDM and CSM, with variance components estimates smaller but more precise as those obtained by Aerts et al. [<xref rid="pone.0234723.ref013" ref-type="bibr">13</xref>]. The correlation between those random effects was negative (-0.29 with se = 0.11), indicating that, while correcting for the other factors and across EAs, couples with a higher value for CDM tend to have a lower value for CSM.</p><p>Our analysis shows that &#x0201c;union number for woman&#x0201d; and &#x0201c;number of partners of man&#x0201d; have a significant effect on the CFP. The woman having been married or cohabitated with a man more than once, and the man having more sexual partners in the last 12 months, increases the probability that the female partner is HIV positive, given that both partners differ in their HIV status (ORs 1.84 and 1.21 respectively). For the CDM, all factors &#x0201c;HIV prevalence of province&#x0201d;, &#x0201c;condom use by man&#x0201d; and &#x0201c;STID of man&#x0201d; have a significant negative effect. A province with a higher prevalence of HIV, a couple of which the man did not use a condom the last time he had sexual intercourse with his partner, and a couple of which the man had a sexually transmitted infectious disease or symptoms thereof in the past 12 months, corresponds to a lower probability that only one is HIV positive, given that at least one of the two partners is positive (ORs {0.37,0.32}, 0.53 and 0.21 respectively).</p><p>Next, our analysis shows also a negative effect of &#x0201c;HIV prevalence of province&#x0201d;, &#x0201c;union number for woman&#x0201d;, &#x0201c;union number for man&#x0201d; and the &#x0201c;survey indicator&#x0201d; on the CSM. The man and/or woman having been married or cohabited with a partner before decreases the probability that both are negative given that at most one of the two partners is positive (OR = 0.54 for woman, OR = 0.78 for man, OR = 0.42 for both). The survey indicator only appears in the model for the CSM, with a main effect and an interaction term with &#x0201c;HIV prevalence of province&#x0201d;. A province with a higher prevalence of HIV implies a lower probability that both partners are negative given that at most one of the two partners is positive (ORs {0.45,0.23} for the INSIDA survey and {exp(-0.79+0.49) = 0.74, exp(-1.46+1.01) = 0.64} for the IMASIDA survey). So, the effect of the &#x0201c;HIV prevalence of province&#x0201d; is weaker in the IMASIDA. Moreover, regardless of the level of prevalence of HIV, and controlling for all factors in the model, the CSM is significantly lower in the second survey. Finally, the &#x0201c;wealth index&#x0201d; has a positive effect, implying that being a &#x0201c;poorer&#x0201d; or &#x0201c;middle&#x0201d; category couple has a higher probability that both partners are negative given that at most one of the two partners is positive (OR = 1.97 and 1.63 and respectively), again while correcting for the effects of all other factors (<xref rid="pone.0234723.t003" ref-type="table">Table 3</xref>).</p><table-wrap id="pone.0234723.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0234723.t003</object-id><label>Table 3</label><caption><title>Estimates (standard errors) of the final model with partial-correlated random effects (<italic>b</italic><sub>CDM,<italic>i</italic></sub>, <italic>b</italic><sub>CSM,<italic>i</italic></sub>) with and no random effect (<italic>b</italic><sub>CFP,<italic>i</italic></sub>).</title></caption><alternatives><graphic id="pone.0234723.t003g" xlink:href="pone.0234723.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Effects</th><th align="center" rowspan="1" colspan="1">CFP</th><th align="center" rowspan="1" colspan="1">CDM</th><th align="center" rowspan="1" colspan="1">CSM</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Intercept</bold></td><td align="center" rowspan="1" colspan="1">-0.76(0.20)<xref ref-type="table-fn" rid="t003fn001">*</xref></td><td align="center" rowspan="1" colspan="1">1.51(0.30)<xref ref-type="table-fn" rid="t003fn001">*</xref></td><td align="center" rowspan="1" colspan="1">3.10(0.24)<xref ref-type="table-fn" rid="t003fn001">*</xref></td></tr><tr><td align="left" colspan="4" rowspan="1"><bold>HIV prevalence of province</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">[5&#x02013;15%]</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-0.99(0.28)<xref ref-type="table-fn" rid="t003fn001">*</xref></td><td align="center" rowspan="1" colspan="1">-0.79(0.24)<xref ref-type="table-fn" rid="t003fn001">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">[&#x0003e; 15%]</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-1.15(0.30)<xref ref-type="table-fn" rid="t003fn001">*</xref></td><td align="center" rowspan="1" colspan="1">-1.46(0.26)<xref ref-type="table-fn" rid="t003fn001">*</xref></td></tr><tr><td align="left" colspan="4" rowspan="1"><bold>Wealth index</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Poorer</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.16(0.22)</td><td align="center" rowspan="1" colspan="1">0.68(0.15)<xref ref-type="table-fn" rid="t003fn001">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Middle</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.39(0.25)</td><td align="center" rowspan="1" colspan="1">0.49(0.16)<xref ref-type="table-fn" rid="t003fn001">*</xref></td></tr><tr><td align="left" colspan="4" rowspan="1"><bold>Condom use by woman</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">0.79(0.45)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" colspan="4" rowspan="1"><bold>Condom use by man</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-0.64(0.22)<xref ref-type="table-fn" rid="t003fn001">*</xref></td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" colspan="4" rowspan="1"><bold>STID for man</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-1.55(0.23)<xref ref-type="table-fn" rid="t003fn001">*</xref></td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" colspan="4" rowspan="1"><bold>Union number for woman</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">More than once</td><td align="center" rowspan="1" colspan="1">0.61(0.24)<xref ref-type="table-fn" rid="t003fn001">*</xref></td><td align="center" rowspan="1" colspan="1">-0.33(0.18)</td><td align="center" rowspan="1" colspan="1">-0.62(0.13)<xref ref-type="table-fn" rid="t003fn001">*</xref></td></tr><tr><td align="left" colspan="4" rowspan="1"><bold>Union number for man</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">More than once</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-0.25(0.10)<xref ref-type="table-fn" rid="t003fn001">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold># of partners for man</bold></td><td align="center" rowspan="1" colspan="1">0.19(0.09)<xref ref-type="table-fn" rid="t003fn001">*</xref></td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" colspan="4" rowspan="1"><bold>Survey indicator</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">IMASIDA</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-0.73(0.25)<xref ref-type="table-fn" rid="t003fn001">*</xref></td></tr><tr><td align="left" colspan="4" rowspan="1"><bold>Survey indicator x HIV prevalence of province</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">IMASIDA x [5&#x02013;15%]</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.49(0.30)</td></tr><tr><td align="left" rowspan="1" colspan="1">IMASIDA x [&#x0003e; 15%]</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.01(0.32)<xref ref-type="table-fn" rid="t003fn001">*</xref></td></tr><tr><td align="left" colspan="4" rowspan="1"><bold>Variance Components</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x003c3;</italic><sup>2</sup><sub>CDM</sub></td><td align="center" rowspan="1" colspan="1">-</td><td align="center" colspan="2" rowspan="1">0.36(0.16)<xref ref-type="table-fn" rid="t003fn002">&#x02020;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x003c1;</italic><sub>CDM,CSM</sub></td><td align="center" rowspan="1" colspan="1">-</td><td align="center" colspan="2" rowspan="1">-0.29(0.11)<xref ref-type="table-fn" rid="t003fn001">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x003c3;</italic><sup>2</sup><sub>CSM</sub></td><td align="center" rowspan="1" colspan="1">-</td><td align="center" colspan="2" rowspan="1">0.47(0.11)<xref ref-type="table-fn" rid="t003fn002">&#x02020;</xref></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>*Significant at 5% level based on a likelihood ratio test,</p></fn><fn id="t003fn002"><p><sup>&#x02020;</sup> Significant at 5% level, using <inline-formula id="pone.0234723.e016"><alternatives><graphic id="pone.0234723.e016g" xlink:href="pone.0234723.e016"/><mml:math id="M16"><mml:msubsup><mml:mrow><mml:mi>&#x003c7;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mspace width="2pt"/><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> mixture.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec009"><title>Conclusions and discussion</title><p>This paper investigated the relationship/association between the HIV status of woman and man within a couple and the risk factors in terms of three conditional probabilities, as introduced by Aerts et al. [<xref rid="pone.0234723.ref013" ref-type="bibr">13</xref>]: the CFP (being the probability that the female partner is HIV positive, given that both partners disagree in their HIV status), the CDM that only one partner is HIV positive, given that at least one of the two partners is positive (&#x0201c;positive&#x0201d; serodiscordance), and the probability CSM that both are negative given that at most one of the two partners is positive (&#x0201c;negative&#x0201d; seroconcordance).</p><p>The new extended analysis based on the INSIDA(2009) and the IMASIDA(2015) survey reveals similar significant factors and estimates as in the more limited analysis of Aerts et al. [<xref rid="pone.0234723.ref013" ref-type="bibr">13</xref>] on the INSIDA survey only. But the additional significant factors &#x0201c;condom use by man&#x0201d; (no use had a negative effect on the CDM) and &#x0201c;union number for man&#x0201d; (for couples where the man has been married or cohabited with a woman before had a decreased CSM) were identified. The only factor that had a different effect over time (IMASIDA as compared to INSIDA) was the effect of &#x0201c;HIV prevalence of province&#x0201d; on the CSM. The negative effect of a higher HIV prevalence was less pronounced in 2015 for the CSM.</p><p>The results found in this paper are in line with the results found in other studies, although applying different methodologies [<xref rid="pone.0234723.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0234723.ref013" ref-type="bibr">13</xref>]. A Kenyan study among persons aged 18 months to 64 years, found that factors associated with HIV-discordance were &#x0201c;an increasing number of lifetime sexual partners for women&#x0201d; and &#x0201c;lack of male circumcision&#x0201d; and &#x0201c;reporting sexual partners outside of the relationship in the past 12 months for men&#x0201d;. This study underscored the importance of couple-based prevention strategies that focus on reducing sexual transmission of HIV among couples including voluntary medical male circumcision, reduction of number of sexual partners, routine couples HIV counseling and testing and knowledge and disclosure of partner status [<xref rid="pone.0234723.ref017" ref-type="bibr">17</xref>].</p><p>A cross-sectional study conducted in Ethiopia with 154 couples, indicated a high prevalence of HIV discordance and increased risk of vulnerability. They recommended that couples should be aware of their own and their partners&#x02019; serostatus before and after engagement. Furthermore, the following risk reduction methods were recommended: education of discordant couples on 100% correct condom use, and if condom breaks, or if they forget to use, Post-Exposure Prophylaxis must be established; for those who did not volunteer to use condom and/or have a child, early initiation of ART to positive partner [<xref rid="pone.0234723.ref018" ref-type="bibr">18</xref>].</p><p>Based on our findings, we recommend the Mozambican health authorities to promote HIV testing for women and men prior to marriage or living together as well as regular testing for couples. These programs would support couples to prevent transmission once one partner has become infected. Juga et al. [<xref rid="pone.0234723.ref009" ref-type="bibr">9</xref>] and Kaiser et al. [<xref rid="pone.0234723.ref017" ref-type="bibr">17</xref>] also advocated that prevention interventions should begin early in relationships and include mutual knowledge of HIV status.</p><p>Finally, our study has some important limitations. Both surveys are cross-sectional. Some couples might have participated in both studies, but as no couple ID was available, our model and analysis could not reflect such double participation. Nevertheless, given the design of the studies and the random selection of couples, it is to be expected that the large majority of couples in both surveys is different. A design in which the same couples were included in the second survey (matched couples) would facilitate a study of which factors have an effect on a change in the positive serodiscordance and negative seroconcordance status within a couple.</p><p>Another limitation of the surveys and our study is that couples, who were unmarried or not cohabiting together, such as teenagers and young adults, were not included. The surveys only provide data of cohabiting couples who, during the individual interviews, responded to be married or living together, and who identified their spouse/wife. Partner concurrency is also a common finding in serodiscordant couples. In both surveys INSIDA and IMASIDA, a particular question was informing about other sexual partners besides the partner of the couple. However, missingness of this variable was of the order of 60%. As one cannot assume such missingness to be ignorable and as methodology for non-ignorable missingness is complicating analysis considerably, we decided to not include this variable.</p></sec><sec sec-type="supplementary-material" id="sec010"><title>Supporting information</title><supplementary-material content-type="local-data" id="pone.0234723.s001"><label>S1 Appendix</label><caption><title>SAS code for the final partial-correlated random EA-effects model (see results in <xref rid="pone.0234723.t003" ref-type="table">Table 3</xref>).</title><p>(DOCX)</p></caption><media xlink:href="pone.0234723.s001.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0234723.s002"><label>S1 Data</label><caption><p>(XLSX)</p></caption><media xlink:href="pone.0234723.s002.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>This study was only possible thanks to the Mozambican Health Ministry (MISAU) and DHS Program for providing the 2009 INSIDA and 2015 IMASIDA survey data. The authors also thank the editors and the reviewers for their valuable and constructive comments and suggestions, which improved the presentation of the paper considerably.</p></ack><ref-list><title>References</title><ref id="pone.0234723.ref001"><label>1</label><mixed-citation publication-type="other">World Health Organisation, &#x0201c;Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach,&#x0201d; WHO Guidel., 2013.</mixed-citation></ref><ref id="pone.0234723.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Guthrie</surname><given-names>B. L.</given-names></name>, <name><surname>de Bruyn</surname><given-names>G.</given-names></name>, and <name><surname>Farquhar</surname><given-names>C.</given-names></name>, &#x0201c;<article-title>HIV-1-discordant couples in sub-Saharan Africa: explanations and implications for high rates of discordancy</article-title>,&#x0201d; <source><italic toggle="yes">Curr</italic>. <italic toggle="yes">HIV Res</italic></source>., <year>2007</year>, <fpage>416</fpage>&#x02013;<lpage>429</lpage>: <volume>14</volume>, <pub-id pub-id-type="doi">10.2174/157016207781023992</pub-id>
<?supplied-pmid 17627505?><pub-id pub-id-type="pmid">17627505</pub-id></mixed-citation></ref><ref id="pone.0234723.ref003"><label>3</label><mixed-citation publication-type="other">J. D. Fishel, S. E. K. Bradley, P. W. Young, F. Mbofana, and C. Botao, &#x0201c;HIV among couples in Mozambique: HIV status, knowledge of status, and factors associated with HIV serodiscordance,&#x0201d; DHS Furth. Anal. Rep., 2011, Calverton, Maryland, USA: ICF International.</mixed-citation></ref><ref id="pone.0234723.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Eyawo</surname><given-names>O.</given-names></name>, <name><surname>de Walque</surname><given-names>D.</given-names></name>, <name><surname>Ford</surname><given-names>N.</given-names></name>, <name><surname>Gakii</surname><given-names>G.</given-names></name>, <name><surname>Lester</surname><given-names>R. T.</given-names></name>, and <name><surname>Mills</surname><given-names>E. J.</given-names></name>, &#x0201c;<article-title>HIV status in discordant couples in sub-Saharan Africa: a systematic review and meta-analysis</article-title>,&#x0201d; <source><italic toggle="yes">Lancet Infect</italic>. <italic toggle="yes">Dis</italic></source>., <year>2010</year>, <month>11</month>;<volume>10</volume>(<issue>11</issue>):<fpage>770</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(10)70189-4</pub-id>
<?supplied-pmid 20926347?><pub-id pub-id-type="pmid">20926347</pub-id></mixed-citation></ref><ref id="pone.0234723.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Bunnell</surname><given-names>R.</given-names></name>, <name><surname>Mermin</surname><given-names>J.</given-names></name>, and <name><surname>De Cock</surname><given-names>K. M.</given-names></name>, &#x0201c;<article-title>HIV prevention for a threatened continent: Implementing positive prevention in Africa</article-title>,&#x0201d; <source><italic toggle="yes">Journal of the American Medical Association</italic></source>. <year>2006</year>, <month>8</month>
<day>16</day>;<volume>296</volume>(<issue>7</issue>):<fpage>855</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1001/jama.296.7.855</pub-id> .<?supplied-pmid 16905790?><pub-id pub-id-type="pmid">16905790</pub-id></mixed-citation></ref><ref id="pone.0234723.ref006"><label>6</label><mixed-citation publication-type="other">J. C. Reed, Mozambique DHS 2015 (2018). IMASIDA&#x02014;Malaria, HIV/AIDS, and Immunization Indicator Survey in Mozambique (2018). IMASIDA&#x02014;Inqu&#x000e9;rito de Indicadores de Imuniza&#x000e7;&#x000e3;o, Mal&#x000e1;ria e HIV/SIDA. 2018, Calverton, Maryland, USA: ICF International.</mixed-citation></ref><ref id="pone.0234723.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Fishel</surname><given-names>J. D.</given-names></name>, <name><surname>Bradley</surname><given-names>S. E.</given-names></name>, <name><surname>Young</surname><given-names>P. W.</given-names></name>, <name><surname>Mbofana</surname><given-names>F.</given-names></name>, and <name><surname>Botao</surname><given-names>C.</given-names></name>, &#x0201c;<article-title>One in ten couples in Mozambique is serodiscordant and most do not know it: Results from the 2009 national HIV seroprevalence survey</article-title>,&#x0201d; <source><italic toggle="yes">J</italic>. <italic toggle="yes">Int</italic>. <italic toggle="yes">AIDS Soc</italic>.</source>, <year>2012</year>, <italic>Calverton</italic>, <italic>Maryland</italic>, <italic>USA</italic>: <italic>ICF International</italic>.</mixed-citation></ref><ref id="pone.0234723.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Tam</surname><given-names>V.</given-names></name>
<etal>et al</etal>, &#x0201c;<article-title>HIV sero-discordance among married HIV patients initiating anti-retroviral therapy in northern Vietnam</article-title>,&#x0201d; <source><italic toggle="yes">AIDS Res</italic>. <italic toggle="yes">Ther</italic></source>., <day>13</day>, <volume>39</volume> (<year>2016</year>), <ext-link ext-link-type="uri" xlink:href="https://DOI.org/10.1186/s12981-016-0124-9">https://DOI.org/10.1186/s12981-016-0124-9</ext-link>.</mixed-citation></ref><ref id="pone.0234723.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Juga</surname><given-names>A. J. C.</given-names></name>, <name><surname>Hens</surname><given-names>N.</given-names></name>, <name><surname>Osman</surname><given-names>N.</given-names></name>, and <name><surname>Aerts</surname><given-names>M.</given-names></name>, &#x0201c;<article-title>A flexible method to model HIV serodiscordance among couples in Mozambique</article-title>,&#x0201d; <source><italic toggle="yes">PLoS ONE</italic></source>
<volume>12</volume>(<issue>3</issue>): <fpage>e0172959</fpage>,<pub-id pub-id-type="doi">10.1371/journal.pone.0172959</pub-id>
<?supplied-pmid 28253283?><pub-id pub-id-type="pmid">28253283</pub-id></mixed-citation></ref><ref id="pone.0234723.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Uah</surname><given-names>I. A. O.</given-names></name>, <name><surname>Ezechi</surname><given-names>O. C.</given-names></name>, and <name><surname>Ohihoin</surname><given-names>A. G.</given-names></name>, &#x0201c;<article-title>HIV Status Discordance: Associated Factors Among HIV Positive Pregnant Women in Lagos, Southwest Nigeria</article-title>.,&#x0201d; <source><italic toggle="yes">Afr</italic>. <italic toggle="yes">J</italic>. <italic toggle="yes">Reprod</italic>. <italic toggle="yes">Health</italic></source>, <year>2015</year>
<month>6</month>;<volume>19</volume>(<issue>2</issue>):<fpage>108</fpage>&#x02013;<lpage>16</lpage>, .<?supplied-pmid 26506663?><pub-id pub-id-type="pmid">26506663</pub-id></mixed-citation></ref><ref id="pone.0234723.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Habte</surname><given-names>E.</given-names></name>
<etal>et al</etal>, &#x0201c;<article-title>Predictors of HIV serodiscordance among couples in southwestern Ethiopia</article-title>,&#x0201d; <source><italic toggle="yes">J</italic>. <italic toggle="yes">Int</italic>. <italic toggle="yes">Assoc</italic>. <italic toggle="yes">Provid</italic>. <italic toggle="yes">AIDS Care</italic></source>, <year>2015</year>, <season>May-Jun</season>;<volume>14</volume>(<issue>3</issue>):<fpage>234</fpage>&#x02013;<lpage>40</lpage>, <pub-id pub-id-type="doi">10.1177/2325957413488177</pub-id> Epub 2013 May 22. <?supplied-pmid 23697776?><pub-id pub-id-type="pmid">23697776</pub-id></mixed-citation></ref><ref id="pone.0234723.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>Y. J.</given-names></name>
<etal>et al</etal>, &#x0201c;<article-title>HIV transmission and related risk factors among serodiscordant couples in Liuzhou, China</article-title>,&#x0201d; <source><italic toggle="yes">J</italic>. <italic toggle="yes">Med</italic>. <italic toggle="yes">Virol</italic></source>., <year>2015</year>, <month>4</month>;<volume>87</volume>(<issue>4</issue>):<fpage>553</fpage>&#x02013;<lpage>6</lpage>, <pub-id pub-id-type="doi">10.1002/jmv.24093</pub-id> Epub 2015 Jan 12. <?supplied-pmid 25583348?><pub-id pub-id-type="pmid">25583348</pub-id></mixed-citation></ref><ref id="pone.0234723.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Aerts</surname><given-names>M.</given-names></name>, <name><surname>Juga</surname><given-names>A. J. C.</given-names></name>, and <name><surname>Hens</surname><given-names>N.</given-names></name>, &#x0201c;<article-title>Measures for concordance and discordance with applications in disease control and prevention</article-title>,&#x0201d; <source><italic toggle="yes">Stat</italic>. <italic toggle="yes">Methods Med</italic>. <italic toggle="yes">Res</italic></source>., <year>2019</year>, <season>Oct-Nov</season>;<volume>28</volume>(<issue>10&#x02013;11</issue>):<fpage>3086</fpage>&#x02013;<lpage>3099</lpage>, <pub-id pub-id-type="doi">10.1177/0962280218796252</pub-id>, Epub 2018 Sep 3. <?supplied-pmid 30175683?><pub-id pub-id-type="pmid">30175683</pub-id></mixed-citation></ref><ref id="pone.0234723.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Faes</surname><given-names>C.</given-names></name>
<etal>et al</etal>, &#x0201c;<article-title>A flexible method to measure synchrony in neuronal firing</article-title>,&#x0201d; <source><italic toggle="yes">J</italic>. <italic toggle="yes">Am</italic>. <italic toggle="yes">Stat</italic>. <italic toggle="yes">Assoc</italic></source>., <year>2008</year>, <volume>103</volume>:<issue>481</issue>, <fpage>149</fpage>&#x02013;<lpage>161</lpage>, <pub-id pub-id-type="doi">10.1198/016214507000000419</pub-id></mixed-citation></ref><ref id="pone.0234723.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Akaike</surname><given-names>H.</given-names></name>, &#x0201c;<article-title>Information theory and an extensi&#x000f3;n of the maximum likelihood principle</article-title>,&#x0201d; <source><italic toggle="yes">Int</italic>. <italic toggle="yes">Symp</italic>. <italic toggle="yes">Inf</italic>. <italic toggle="yes">theory</italic></source>, <year>1973</year>, <pub-id pub-id-type="doi">10.1007/978-1-4612-1694-0_15</pub-id>.</mixed-citation></ref><ref id="pone.0234723.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Schwarz</surname><given-names>G.</given-names></name>, &#x0201c;<article-title>Estimating the Dimension of a Model</article-title>,&#x0201d; <source><italic toggle="yes">Ann</italic>. <italic toggle="yes">Stat</italic></source>., <year>1978</year>, <volume>Vol. 6</volume>, <issue>No. 2</issue> (<month>3</month>, <year>1978</year>), pp. <fpage>461</fpage>&#x02013;<lpage>464</lpage>.</mixed-citation></ref><ref id="pone.0234723.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Kaiser</surname><given-names>R.</given-names></name>
<etal>et al</etal>, &#x0201c;<article-title>Factors associated with HIV infection in married or cohabitating couples in Kenya: Results from a nationally representative study</article-title>,&#x0201d; <source><italic toggle="yes">PLoS One</italic></source>, <year>2011</year>, <month>3</month>
<day>15</day>;<volume>6</volume>(<issue>3</issue>):<fpage>e17842</fpage>, <pub-id pub-id-type="doi">10.1371/journal.pone.0017842</pub-id>
<?supplied-pmid 21423615?><pub-id pub-id-type="pmid">21423615</pub-id></mixed-citation></ref><ref id="pone.0234723.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Tadesse</surname><given-names>M.</given-names></name>, &#x0201c;<article-title>Assessment of HIV discordance and associated risk factors among couples receiving HIV test in Dilla, Ethiopia</article-title>,&#x0201d; <source><italic toggle="yes">BMC Res</italic>. <italic toggle="yes">Notes</italic></source>, <year>2014</year>, <volume>7</volume>: <fpage>893</fpage>, <pub-id pub-id-type="doi">10.1186/1756-0500-7-893</pub-id>, .<?supplied-pmid 25491642?><pub-id pub-id-type="pmid">25491642</pub-id></mixed-citation></ref></ref-list></back></article>